MRI in combination with Technetium‐99m‐sestamibi single‐photon emission CT/CT: a novel diagnostic algorithm to maximise the characterisation of small renal masses

Table S1. Sociodemographic and clinical characteristics of patients who underwent sestamibi SPECT/CT and MRI with available ccLS and histopathology. Table S2. Diagnostic performance of 99mTc-sestamibi SPECT/CT alone, MRI alone and their combination in preoperative characterisation of cT1a indeterminate renal masses. Fig. S1. Receiver-operating characteristic (ROC) curves displaying the diagnostic performance of SPECT/CT sestamibi alone, MRI alone, and the combination of both modalities in identifying ccRCC, when lesions with a ccLS of 3 are considered as ccRCC (Panel A) and when ccLS 3 lesions are instead categorised as other histologies (Panel B). Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Authors

Institutions

Publication Details

Journal
British Journal of Urology
Published
2025-09-23
DOI
https://doi.org/10.1111/bju.70002
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

MRI in combination with Technetium‐99m‐sestamibi single‐photon emission CT/CT: a novel diagnostic algorithm to maximise the characterisation of small renal masses

Alessandro Bertini, Alessandro Larcher, Francesco De Cobelli, Roberto Bertini et al.
British Journal of Urology
Renal cell carcinoma treatment
article

MRI in combination with Technetium‐99m‐sestamibi single‐photon emission CT/CT: a novel diagnostic algorithm to maximise the characterisation of small renal masses

Alessandro Bertini, Alessandro Larcher, Francesco De Cobelli, Roberto Bertini, Giuseppe Basile, Andrea Salonia, Giorgio Brembilla, Francesco Montorsi, Francesco Prato, Giuseppe Rosiello, Arturo Chiti, Umberto Capitanio, Giulio Imperiale, Riccardo Zurrida
article en

Abstract

Table S1. Sociodemographic and clinical characteristics of patients who underwent sestamibi SPECT/CT and MRI with available ccLS and histopathology. Table S2. Diagnostic performance of 99mTc-sestamibi SPECT/CT alone, MRI alone and their combination in preoperative characterisation of cT1a indeterminate renal masses. Fig. S1. Receiver-operating characteristic (ROC) curves displaying the diagnostic performance of SPECT/CT sestamibi alone, MRI alone, and the combination of both modalities in identifying ccRCC, when lesions with a ccLS of 3 are considered as ccRCC (Panel A) and when ccLS 3 lesions are instead categorised as other histologies (Panel B). Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

British Journal of UrologyVol. 137(2)
Vita-Salute San Raffaele University (IT), Royal Free London NHS Foundation Trust (GB), Center for Health and Gender Equity (US), IRCCS Ospedale San Raffaele (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
Openalex Percentile: Top 63%
Renal cell carcinoma treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.